Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Keith A Hruska

Showing results (1-10 of 80) with videos related to

Pageof 8
Sort By:
Kidney International|April 23, 2002
Treatment of chronic tubulointerstitial disease: a new conceptKeith A Hruska
Circulation Research|March 28, 2009
Vascular smooth muscle cells in the pathogenesis of vascular calcificationKeith A Hruska
The Journal of Biological Chemistry|November 17, 2004
Akt1/Akt2 and mammalian target of rapamycin/Bim play critical roles in osteoclast differentiation and survival, respectively, whereas Akt is dispensable for cell survival in isolated osteoclast precursorsToshifumi Sugatani, Keith A Hruska
Journal of Cellular Biochemistry|December 15, 2012
Down-regulation of miR-21 biogenesis by estrogen action contributes to osteoclastic apoptosisToshifumi Sugatani, Keith A Hruska
Advances in Chronic Kidney Disease|March 17, 2011
The roles of the skeleton and phosphorus in the CKD mineral bone disorderKeith A Hruska, Suresh Mathew
The Journal of Biological Chemistry|December 9, 2008
Impaired micro-RNA pathways diminish osteoclast differentiation and functionToshifumi Sugatani, Keith A Hruska
Journal of Cellular Biochemistry|April 12, 2003
Inhibition of cell survival signal protein kinase B/Akt by curcumin in human prostate cancer cellsLala R Chaudhary, Keith A Hruska
Journal of the American Society of Nephrology : JASN|March 31, 2023
Acidosis in CKD May Affect Mineralization of Newly Formed Bone According to HR-pQCT and Quantitative Back Scatter Electron ImagingMatthew J Williams, Keith A Hruska
Transplantation|September 11, 2015
The Kidney-Vascular-Bone Axis in the Chronic Kidney Disease-Mineral Bone DisorderMichael E Seifert, Keith A Hruska
Kidney International|January 23, 2019
New pathogenic insights inform therapeutic target development for renal osteodystrophyKeith A Hruska, Moe R Mahjoub
Pageof 8

Showing results (1-10 of 80) with videos related to

Sort By:
Pageof 8
Kidney International|April 23, 2002
Treatment of chronic tubulointerstitial disease: a new conceptKeith A Hruska
Circulation Research|March 28, 2009
Vascular smooth muscle cells in the pathogenesis of vascular calcificationKeith A Hruska
The Journal of Biological Chemistry|November 17, 2004
Akt1/Akt2 and mammalian target of rapamycin/Bim play critical roles in osteoclast differentiation and survival, respectively, whereas Akt is dispensable for cell survival in isolated osteoclast precursorsToshifumi Sugatani, Keith A Hruska
Journal of Cellular Biochemistry|December 15, 2012
Down-regulation of miR-21 biogenesis by estrogen action contributes to osteoclastic apoptosisToshifumi Sugatani, Keith A Hruska
Advances in Chronic Kidney Disease|March 17, 2011
The roles of the skeleton and phosphorus in the CKD mineral bone disorderKeith A Hruska, Suresh Mathew
The Journal of Biological Chemistry|December 9, 2008
Impaired micro-RNA pathways diminish osteoclast differentiation and functionToshifumi Sugatani, Keith A Hruska
Journal of Cellular Biochemistry|April 12, 2003
Inhibition of cell survival signal protein kinase B/Akt by curcumin in human prostate cancer cellsLala R Chaudhary, Keith A Hruska
Journal of the American Society of Nephrology : JASN|March 31, 2023
Acidosis in CKD May Affect Mineralization of Newly Formed Bone According to HR-pQCT and Quantitative Back Scatter Electron ImagingMatthew J Williams, Keith A Hruska
Transplantation|September 11, 2015
The Kidney-Vascular-Bone Axis in the Chronic Kidney Disease-Mineral Bone DisorderMichael E Seifert, Keith A Hruska
Kidney International|January 23, 2019
New pathogenic insights inform therapeutic target development for renal osteodystrophyKeith A Hruska, Moe R Mahjoub
Pageof 8